Clinical Study
User Acceptability of P3L
Full Title
User Acceptability of a Nicotine Lactate Delivery System Relative to the VUSE e-Cigarette System and Combustible Cigarette Comparators
Authored by
PMI
Abstract
This study will provide an initial assessment of the acceptability of the Nicotine Lactate Delivery System (P3L) after ad libitum use and the ability of combustible cigarette (CC) smokers to use P3L to maintain their customary nicotine intake. The pharmacokinetics (PK) and pharmacodynamics (PD, i.e., subjective effects) profiles, will be evaluated as well as the safety and tolerability of the P3L.
Summary
Recruitment | Completed |
Study Results | No Results Available |
Enrollment | 24 |
Study Type | Interventional |
Other IDs | P3L-PK-02-US |
-
Published On
March 3, 2017 -
Full publication
-
Identifier
NCT02643693